Deloitte

Digitizing the Biopharmaceutical Supply Chain Improves Resilience

January 30, 2024 - Throughout the past few years, global, national, and industry-specific changes have posed challenges to the biopharmaceutical supply chain. Disruptions and shortages have caused industry leaders and regulatory organizations to look for alternative solutions to restore and enhance these supply chains, building resilience in anticipation of future challenges. Recently, the Deloitte...


More Articles

Analyzing Returns on Investment from Pharmaceutical Innovation

by Veronica Salib

In an annual report focused on the return on investment (ROI) from pharmaceutical innovation, Deloitte analyzed research and development (R&D) in the pharmaceutical industry and the resulting outcomes throughout 2022. Considering the...